ConvaTec Group (LON:CTEC) Hits New 1-Year Low at $2.63

Shares of ConvaTec Group PLC (LON:CTEC - Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as GBX 2.63 ($0.03) and last traded at GBX 260 ($3.27), with a volume of 10982048 shares traded. The stock had previously closed at GBX 266.20 ($3.34).

Analysts Set New Price Targets

Several brokerages recently weighed in on CTEC. Berenberg Bank boosted their target price on ConvaTec Group from GBX 290 ($3.64) to GBX 310 ($3.89) and gave the stock a "buy" rating in a research note on Wednesday, March 6th. JPMorgan Chase & Co. boosted their price target on ConvaTec Group from GBX 300 ($3.77) to GBX 323 ($4.06) and gave the company an "overweight" rating in a research note on Thursday, March 7th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of GBX 307.17 ($3.86).

ConvaTec Group Trading Down 4.1 %

The firm has a market cap of £5.24 billion, a price-to-earnings ratio of 5,108.00, a PEG ratio of 2.16 and a beta of 0.60. The company has a fifty day moving average price of GBX 277.71 and a 200-day moving average price of GBX 250.30. The company has a current ratio of 1.62, a quick ratio of 0.96 and a debt-to-equity ratio of 77.53.

ConvaTec Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, May 23rd. Stockholders of record on Thursday, April 25th will be issued a $0.04 dividend. This represents a dividend yield of 1.39%. The ex-dividend date of this dividend is Thursday, April 25th. This is a boost from ConvaTec Group's previous dividend of $0.02. ConvaTec Group's payout ratio is 10,000.00%.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.